Fluid resuscitation in patients with cirrhosis and hypovolemia in the central compartment from sepsis is a balancing act, and the lack of positive findings from our study concerning albumin use provides further guidance for clinicians seeking to optimize outcomes in this complex patient population. This evidence concerns the gene ALB and Sepsis.